Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction

NCT06059066 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Neurogenic Bladder
Lower Urinary Tract Symptoms
Overactive Bladder
Neuro: Neurogenic Bladder
Neurogenic Detrusor Overactivity

Interventions

PROCEDURE: Standard number of injection sites
PROCEDURE: Reduced number of injection sites

Sponsor

The Methodist Hospital Research Institute

Collaborators

[object Object]